• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ICTUS研究:一项对欧洲1380例急性冠脉综合征患者的前瞻性纵向观察研究。队列的研究设计和基线特征。

The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort.

作者信息

Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni G B, Jönsson L, Visser P J, Ousset P J, Vellas B

机构信息

Inserm, U558, Toulouse, France.

出版信息

Neuroepidemiology. 2007;29(1-2):29-38. doi: 10.1159/000108915. Epub 2007 Sep 24.

DOI:10.1159/000108915
PMID:17898521
Abstract

The long-term objective of the ICTUS study is to identify milestones in Alzheimer's disease (AD) progression and to develop a model to predict disease course in individual AD patients in Europe. The secondary objectives are to describe the patterns of prescribing, and the socioeconomic impact of AD in Europe. Between 2003 and 2005 1,380 patients with probable AD were recruited in specialised (secondary care) clinics in 12 European countries. Their mean age was 76 years and they had a mean of 8.0 +/- (SD) 4.6 years of education. Thirty-five percent were male. The mean MMSE score was 20.4 +/- (SD) 4.0. Forty-three percent had very mild dementia (CDR 0.5) and 44% had mild dementia (CDR 1). All patients completed baseline evaluation and biannual follow-up is ongoing. The goals of the current study are to describe the specific methods for recruitment in this crosscultural setting and the characteristics of the inception ICTUS cohort, including clinical features, co-morbidity, neuropsychological performance, neuropsychiatric symptoms, functional impairment and social burden.

摘要

ICTUS研究的长期目标是确定阿尔茨海默病(AD)进展中的里程碑事件,并开发一个模型来预测欧洲个体AD患者的病程。次要目标是描述欧洲AD的处方模式以及社会经济影响。2003年至2005年期间,在欧洲12个国家的专科(二级护理)诊所招募了1380例可能患有AD的患者。他们的平均年龄为76岁,平均受教育年限为8.0 +/-(标准差)4.6年。35%为男性。平均MMSE评分为20.4 +/-(标准差)4.0。43%患有极轻度痴呆(CDR 0.5),44%患有轻度痴呆(CDR 1)。所有患者均完成了基线评估,目前正在进行每年两次的随访。本研究的目的是描述在这种跨文化背景下的具体招募方法以及初始ICTUS队列的特征,包括临床特征、合并症、神经心理学表现、神经精神症状、功能障碍和社会负担。

相似文献

1
The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort.ICTUS研究:一项对欧洲1380例急性冠脉综合征患者的前瞻性纵向观察研究。队列的研究设计和基线特征。
Neuroepidemiology. 2007;29(1-2):29-38. doi: 10.1159/000108915. Epub 2007 Sep 24.
2
A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort).对233名极轻度(临床痴呆评定量表评分为0.5)阿尔茨海默病患者进行的为期2年的随访(REAL.FR队列)。
Int J Geriatr Psychiatry. 2008 May;23(5):460-5. doi: 10.1002/gps.1904.
3
Regional variation on the presentation of Alzheimer's disease patients in memory clinics within Europe: data from the ICTUS study.欧洲记忆诊所中阿尔茨海默病患者表现的地域差异:来自 ICTUS 研究的数据。
J Alzheimers Dis. 2010;21(1):155-65. doi: 10.3233/JAD-2010-091489.
4
Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?多奈哌齐治疗与阿尔茨海默病:随机临床试验的结果能否应用于临床实践中的阿尔茨海默病患者?
Am J Geriatr Psychiatry. 2007 Nov;15(11):953-60. doi: 10.1097/JGP.0b013e3180986138.
5
Alzheimer's disease progression in the oldest old compared to younger elderly patient: data from the REAL.FR study.与年轻老年患者相比,最年长老年人的阿尔茨海默病进展:来自REAL.FR研究的数据。
Int J Geriatr Psychiatry. 2009 Feb;24(2):149-55. doi: 10.1002/gps.2084.
6
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.阿托伐他汀/多奈哌齐治疗阿尔茨海默病研究(LEADe):设计与基线特征
Alzheimers Dement. 2008 Mar;4(2):145-53. doi: 10.1016/j.jalz.2008.02.001.
7
Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study.阿尔茨海默病患者内侧颞叶萎缩的多中心比较——来自ICTUS研究的数据。
Dement Geriatr Cogn Disord. 2008;26(4):314-22. doi: 10.1159/000161056. Epub 2008 Oct 8.
8
[Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].[音乐疗法对阿尔茨海默病患者焦虑和抑郁的影响以及对主要照顾者负担的影响(可行性研究)]
Encephale. 2009 Feb;35(1):57-65. doi: 10.1016/j.encep.2007.10.009. Epub 2008 Feb 20.
9
Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.当今阿尔茨海默病的预后:来自REAL-FR研究的686例患者的两年前瞻性研究
Alzheimers Dement. 2008 Jan;4(1):22-9. doi: 10.1016/j.jalz.2007.10.018.
10
Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.从认知障碍但未患痴呆症到阿尔茨海默病的转变:痴呆症门诊队列中功能能力变化的分析
Dement Geriatr Cogn Disord. 2008;25(6):483-90. doi: 10.1159/000126499. Epub 2008 Apr 16.

引用本文的文献

1
Informal care for people with dementia in Europe.欧洲对痴呆症患者的非正式护理。
J Prev Alzheimers Dis. 2025 Jan;12(1):100015. doi: 10.1016/j.tjpad.2024.100015. Epub 2025 Jan 1.
2
European Projects for Patients with Dementia and Their Caregivers.面向痴呆症患者及其护理人员的欧洲项目。
Adv Exp Med Biol. 2023;1425:609-618. doi: 10.1007/978-3-031-31986-0_59.
3
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.阿尔茨海默病的临床前、前驱和痴呆阶段的持续时间与年龄、性别和 APOE 基因型有关。
Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1.
4
kmlShape: An Efficient Method to Cluster Longitudinal Data (Time-Series) According to Their Shapes.KML形状:一种根据纵向数据(时间序列)形状进行聚类的有效方法。
PLoS One. 2016 Jun 3;11(6):e0150738. doi: 10.1371/journal.pone.0150738. eCollection 2016.
5
Retirement age and the age of onset of Alzheimer's disease: results from the ICTUS study.退休年龄与阿尔茨海默病的发病年龄:ICTUS研究结果
PLoS One. 2015 Feb 25;10(2):e0115056. doi: 10.1371/journal.pone.0115056. eCollection 2015.
6
Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.评估共病对阿尔茨海默病临床试验成本影响时的方法学挑战。
Eur J Health Econ. 2015 Dec;16(9):995-1004. doi: 10.1007/s10198-014-0648-7. Epub 2014 Nov 20.
7
Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem).阿尔茨海默病患者的抗痴呆药物及联合用药:利用瑞典痴呆症质量登记系统(SveDem)调查临床实践中的实际用药情况
Drugs Aging. 2014 Mar;31(3):215-24. doi: 10.1007/s40266-014-0154-8.
8
A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.一项针对欧洲轻度至中度阿尔茨海默病患者使用抗痴呆药物持续性的 2 年前瞻性队列研究:ICTUS 研究中停药和换药的预测因素。
CNS Drugs. 2014 Feb;28(2):157-70. doi: 10.1007/s40263-013-0133-3.
9
Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!REAL.FR 队列中阿尔茨海默病患者潜在不适当药物使用:警惕阿托品和苯二氮䓬类药物!
Eur J Clin Pharmacol. 2013 Aug;69(8):1589-97. doi: 10.1007/s00228-013-1506-8. Epub 2013 Apr 16.
10
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.行为亚综合征对阿尔茨海默病认知衰退的影响:来自 ICTUS 研究的数据。
J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1007/s00415-013-6893-3. Epub 2013 Mar 17.